On May 22, 2025, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) convened to evaluate and recommend the formulation of COVID-19 vaccines for the 2025–2026 season, set to begin in the fall.
Click Here to Learn More
FDA Recommends More mRNA Shots Despite New Study Showing Booster Failure—and Major Public Outcry
